Henry Schein's (HSIC) "Neutral" Rating Reaffirmed at Robert W. Baird

Henry Schein (NASDAQ:HSIC - Get Free Report)'s stock had its "neutral" rating reaffirmed by Robert W. Baird in a note issued to investors on Monday, MarketBeat.com reports. They presently have a $72.00 price objective on the stock, down from their previous price objective of $82.00. Robert W. Baird's target price suggests a potential upside of 3.87% from the stock's current price.

Several other equities analysts have also commented on the company. Piper Sandler lowered their price objective on Henry Schein from $83.00 to $77.00 and set an "overweight" rating for the company in a research report on Wednesday, April 30th. Barrington Research lowered their price objective on Henry Schein from $90.00 to $86.00 and set an "outperform" rating for the company in a research report on Tuesday, May 6th. Evercore ISI raised their price objective on Henry Schein from $72.00 to $78.00 and gave the company an "in-line" rating in a research report on Wednesday, July 9th. Wall Street Zen lowered Henry Schein from a "buy" rating to a "hold" rating in a research report on Thursday, April 17th. Finally, Wells Fargo & Company lowered their price target on Henry Schein from $80.00 to $75.00 and set an "equal weight" rating for the company in a research report on Tuesday, May 6th. Eight investment analysts have rated the stock with a hold rating and four have given a buy rating to the company's stock. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and an average target price of $78.36.

Henry Schein Trading Down 1.9%

Shares of Henry Schein stock traded down $1.32 on Monday, hitting $69.32. The stock had a trading volume of 2,134,923 shares, compared to its average volume of 1,747,825. The company has a quick ratio of 0.75, a current ratio of 1.38 and a debt-to-equity ratio of 0.50. Henry Schein has a one year low of $60.56 and a one year high of $82.49. The stock has a market cap of $8.44 billion, a price-to-earnings ratio of 21.66, a PEG ratio of 2.28 and a beta of 0.87. The stock's 50-day simple moving average is $71.73 and its two-hundred day simple moving average is $71.33.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its quarterly earnings results on Monday, May 5th. The company reported $1.15 EPS for the quarter, topping analysts' consensus estimates of $1.11 by $0.04. Henry Schein had a return on equity of 14.87% and a net margin of 3.21%. The company had revenue of $3.17 billion during the quarter, compared to analyst estimates of $3.24 billion. During the same quarter last year, the firm posted $1.10 earnings per share. The firm's revenue was down .1% on a year-over-year basis. As a group, sell-side analysts predict that Henry Schein will post 4.74 EPS for the current year.

Institutional Investors Weigh In On Henry Schein

Several hedge funds and other institutional investors have recently made changes to their positions in HSIC. Guggenheim Capital LLC increased its stake in Henry Schein by 2.5% in the fourth quarter. Guggenheim Capital LLC now owns 6,428 shares of the company's stock worth $445,000 after purchasing an additional 159 shares during the period. Radnor Capital Management LLC increased its stake in Henry Schein by 1.6% in the second quarter. Radnor Capital Management LLC now owns 11,415 shares of the company's stock worth $834,000 after purchasing an additional 180 shares during the period. UMB Bank n.a. increased its stake in Henry Schein by 23.2% in the first quarter. UMB Bank n.a. now owns 1,066 shares of the company's stock worth $73,000 after purchasing an additional 201 shares during the period. Humankind Investments LLC increased its stake in Henry Schein by 7.4% in the fourth quarter. Humankind Investments LLC now owns 3,057 shares of the company's stock worth $212,000 after purchasing an additional 211 shares during the period. Finally, HB Wealth Management LLC increased its stake in Henry Schein by 1.5% in the first quarter. HB Wealth Management LLC now owns 15,419 shares of the company's stock worth $1,056,000 after purchasing an additional 226 shares during the period. Hedge funds and other institutional investors own 96.62% of the company's stock.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.